INTRODUCTION
Polynuclear aromatic hydrocarbons (PNAs) are produced by a variety of combustion processes and have been identified in most coal conversion processes. PNAs are of concern to health scientists because of their proven animal carcinogenicity and strong presumptive evidence of their ability to cause human cancer. The need exists for a convenient biological indicator or 11 yardstick 11 to ll_leasure extent of exposure ,and the response to this exposure iri humans who are employed in industries where ~NAs may be produced. It is proposed that aryl hydrocarbon mono-oxygenase (AHM), the enzyme system responsible for the.initial metabolism of PNAs to water-soluble excretion products, may serve as thi~ biological indicator. To test this hypothesis, AHM activity levels will be measured in peripheral lymphocytes from coal conversion facility workers and a control population at regular intervals over an extended time period. Correlations between alterations in AHM activity (beyond individual variability), nature and extent of PNA exposure (determined by an appropriate industrial monitoring program) and other health parameters of these workers will then be examined.
PNA exposures in animals which have the appropriate genetic characteristics result in very large increases ·in AHM activity (called induction) in these animals. These same genetic strains are also much more susceptible to PNA-induced carcinogenesis than animal strains in which AHM activity cannot be induced. Studies of AHM activity in human peripheral lymphocytes have shown a higher enzyme activity in lymphocytes from smokers than non-smoking controls, and a greater·induction of AHM activity in lymphocytes from lung cancer patients than in appropriate controls, although this latter observation has been questioned. AHM activity levels in peripheral lymphocytes, pulmonary alveolar macrophages and lung biopsy. tissue have been shown to correlate well for a given individual. These observations suggest that AHM activity in peripheral lymphocytes can indeed be an appropriate measure of PNA exposure for those respiratory tissues which appear to be a prime target for PNAinduced carcinogenesis.
l In this discussion, the collection of cytochrome P-450 mono-oxygenase enzymes, which will be labelled as aryl hydrocarbon mono-oxygenase (AHM), is distinguished from the subset of AHM enzymes involved in the production of principally the 3 and 9 phenol derivatives of benzo(a)pyrene (BP) as determined according to the assay method of Nebert and Gelboin 1 or its equivalent. The latter will be designated as aryl hydrocarbon hydroxylase (AHH).
AHH Activity Modulation: Mitogen Stimulation, Disease Process, Genetic Factors
Whitlock et al. 2 studied aryl hydrocarbon hydroxylase activity in human lymphocytes stimulated by mitogens and induced with benz(a)anthracene (BA). They found an enzyme system in these cells which had similar properties to AHH systems from rat liver microsomes. Although AHH activity was measurable in 11 resting 11 lymphocytes, mitogen stimulation [by phytohemagglutinin (PHA) or pokeweed mitogen (PWM)] produced an approximate doubling in activity. If BA was added. during mitogeninduced blastogenesis, AHH activities increased severalfold over mitogenstimulated cultures alone. Busbee et al. 3 examined the time-course of AHH induction by 3-methylcholanthrene (MCA) in human leukocytes stimulated by PHA. They found that MCA induction produced significant increases in AHH activity only at a specific time in the course of PHA stimulation (72 hr after PHA addition); MCA addition to fresh leukocytes caused no induction after a 24 hr exposure. Booth et al.~ demonstrated the production of metabolites from various PNAs including BP, by PHA-stimulated human leukocytes.
Kellermann et al. 5 studied AHH levels in PHA and PWM-stimulated leukocytes from 353 individuals following an induction with MCA according to the time-course studies of Busbee et al.
•
The ratio of the extent of AHH induction (induced activity/non-induced activity) showed a trimodal distribution, with the majority (53%) of the population having low induction ratios of 1-2.5, another sizable proportion (37%) with induction ratios of 2.5-3.5, and the smallest fraction (10%) of the population having induction ratios of 3.5-4.5. In this same paper, the ' ... authors also mention that1 pulmonary alveolar macrophages have AHH activity and this activity is increased by inhalation of cigarette smoke. Further studies by Kellermann et al. 6 , using PHA-stimulated leukocytes, indicated that the extent of induction (at least over a 6 month interval) remained relatively constant in different culture conditions using different inducers, and was quite reproducible for a given individual (i.e., a person with inducibility ratio of 2.0 initially fluctuated from 1.9-2.2, etc.). This same group (Kellermann et al. 7 ) studied AHH inducibility in 50 lung cancer patients and a control population. They found that: in the control population, the AHH inducibility distribution was 45% (low ratio), 46% (medium), and 9% {high ratio); while in the lung cancer patients, only 4% had a low AHH inducibility ratio, and 66% and 30% had medium and high ratios, respectively. This observation raised the hope that it might prove possible to identify individuals who had a higher susceptibility to lung cancer on the basis of AHH activity measurements.
Since these initial observations of Kellermann, a number of different groups have attempted to repeat and extend this work, with varying degrees of success. Guirgis et al. 8 studied AHM activity in BP-induced lymphocytes which had been stimulated with PHA and PWM. These investigators used an assay involving radiolabeled BP, in contrast to Kellermann•s group, which used the Nebert assay, and claimed greater precision for the radiometric assay. Eleven lung cancer patients were compared to 11 controls; AHM activity per unit weight of DNA was higher in the lung cancer patients although there was much variability in the data.
Paigen et al. 9 tried to confirm the claim of increased AHH inducibility in lymphocytes from lung cancer patients, but they could not detect any inducibility (MCA used as inducer) in l/2 (6 of 12) of the lung cancer patients. The amount of DNA per culture was also decreased in these 6 patients. compared to controls, suggesting diminished cell growth. Apparently many of the lymphocytes from lung cancer patients died during the incubation with PHA and PWM. Further studies indicated that surviving mitogen-stimulated lymphocytes from lung cancer patients maintained normal DNA synthesis, but that their protein synthesis was somewhat impaired. One might conclude that lymphocytes from lung cancer patients are probably afflicted with the general debility that goes along with this severe disease and that comparative measurements of AHH activity in these cells are probably not meaningful. Paigen et al. 9 also measured AHH activity and inducibility in progeny of lung cancer patients, reasoning that since AHH inducibility is presumably genetically controlled, if lung cancer patients have a genetically high level of inducible enzyme activity, their progeny should have higher AHH inducibility than the normal population. Such was not the case, however.
A study by Trell et al . 10 appeared to support the earlier work of Kellermann. These investigators studied AHH inducibility in lymphocytes from 34 patients with oral carcinomas (squamous cell varieties only) and found a significantly increased number of these patients belonged to the high AHH inducibility group. This increase, however, was based on an expected distribution calculated from the results of Kellermann, as these investigators did not include controls in their study. Emery et al. 11 studied AHH inducibility in PHA-stimulated lymphocytes from squamous cell lung cancer patients and appropriate controls. The proportion of high inducers (>4, induced/uninduced activity) was significantly greater in lung cancer patients than in controls (43/62 cases for lung cancer patients compared to 21/62 controls). This difference was not seen when patients with other types of cancer were similarly compared.
Jett et al. 12 further investigated AHM activity (as measured by radiolabeled BP metabolism) in PHA and PWM-stimulated lymphocytes from three populations: (l) non-smoking and (2) smoking controls and (3) lung cancer patients. They found BP metabolism to be significantly increased in the smoking control groups compared to the nonsmoking controls and lung cancer patients. The degree of lymphocyte blastogenic transformation (as measured by 3 H-thymidine uptake), however, was significantly decreased in lung cancer patients compared to both control groups. This observation again suggests a severe debility in lymphocytes from lung cancer patients. This group was further able to show a relationship between extent of lymphocyte transformation and degree of BP metabolism. When lymphocytes were stimulated with different doses of mitogens to produce degrees of transformation, the extent of BP metabolism positively correlated with increasing degree of blastogenic transformation. Gahmberg et al. 13 studied AHH activity in PHA and PWM-stimulated lymphocytes after induction with dibenz(a,h)anthracene (DBA), and found high absolute levels of activity were more frequent in pulmonary carcinoma patients than in controls. Of the control population, 85% fell into the low activity group and 15% had mean AHH activity approximately twice as high as the low activity group. In the case of lung cancer patients, 39% fell into the absolute high AHH activity classification. These investigators did not choose to present their data as inducibility ratios because they claimed that small variations in uninduced AHH activity would greatly alter the final ratio.
The work of Atlas et al. 14 was targeted at the question as to whether AHH activity in human lymphocytes is under genetic control, or is more or less randomly determined. Using lymphocytes from twins, it was found that genetic factors did account for much of the interindividual variation encountered in AHH inducibility (by MCA)". They found that the AHH inducibility ratio for a given individual remained more or less constant, but that absolute values of uninduced and induced AHH activity fluctuated widely. The most important determinant of this variability was the particular lot of fetal calf serum (FCS) used in the culture media. The ability of the FCS to support lymphocyte blastogenesis was not the only crucial factor, however, as lots of FCS that supported cell growth equally gave widely differing values of AHH activity.t The authors suggest that differing percentages of 11 T   11   and  11 8   11 lymphocytes, and differing responses to mitogen (PHA and PWM) stimulation might occur in individuals with time, and that these differences could influence AHH activity .. The usefulness of a cellular system in which AHH activity is tThis problem may well result from competition between cells and fetal calf serum for the hydrocarbons, causing variable cell dosages in the AHM induction and/or assay procedures. not coupled with a chemical-cellular blastogenesis stimulus is therefore stressed by these investigators.
The preceding studies provide some indication of the variable and sometimes conflicting results obtained in studies attempting to measure AHH activity in human lymphocytes. A number of workers have attempted to modulate certain parameters of the assay system to reduce this variability. These studies will be briefly summarized in a later section, but suffice it to say at present, that such efforts have so far been unsuccessful in significantly reducing this variability. Certain studies will now be considered which have attempted to correlate AHH activity in a number of human tissues with either PNA exposure or genetic disposition to cancer. Such studies more directly address the problem of the possible relation between AHH activity and conversion of PNAs to carcinogenic metabolites.
AHH Activity Correlations: Dependence on PNA Exposure and Relation to Lung Cancer
Cantrell et al. 15 studied AHH activity in mitogen-stimulated (uninduced and MCA-induced) lymphocytes and in fresh pulmonary alveolar macrophages (PAM) from smokers and nonsmokers. They found that the levels of AHH activity in fresh PAM showed a positive correlation with the lymphocyte AHH inducibility ratio from the same individual, whether smoker or nonsmoker (i.e., individuals with low PAM AHH activity had decreased AHH inducibility in their lymphocytes and vice versa). AHH activity was higher in fresh PAM from smokers than from nonsmokers.
Further work by this same group (Mclemore et al. 16 ) showed that in vitro incubation (24 hr) of human PAMs or mitogen-stimulated lymphocytes with cigarette tar produced increased AHH activity in both cell types (2-3 fold increases over non-cigarette tar-induced cells). Continuing these studies, Mclemore et al. 17 showed that BA or cigarette tar absorbed to asbestos was capable of inducing increased AHH activity in mitogenstimulated human lymphocytes. These series of experiments demonstrated that cigarette smoke components were indeed capable of inducing AHH increases in at least two different human tissues.
• This research group (Mclemore, Burke, Martin, Cantrell, etc.) addressed further experiments to study the relationship between AHH activity in different tissues, and this work is excellently summarized in Busbee et al. 18 Mclemore et al. 19 studied the correlation between AHH activity in lymphocytes and PAM from smokers and nonsmokers with a variety of pulmonary diseases (but no lung cancer patients). Absolute basal (non-PNA induced) AHH activities were higher in PAMs and mitogen-stimulated lymphocytes from smokers (2-2.5 x AHH activity in nonsmokers). Induction with BA (24 hr.s) produced increases in AHH activity in smokers• and nonsmokers• PAMs and lymphocytes which were 3-4 fold above noninduced levels; the induced AHH activity in smokers• lymphocytes was significantly higher than in nonsmokers• lymphocytes, and this same trend was seen for PAMs. There was positive correlation between AHH activity data obtained from PAMs and lymphocytes when basal activity, induced activity or induction ratio was compared for individual smokers or nonsmokers. The conclusion seems to be that the extent of AHH induction in smokers·or nonsmokers, and the AHH inducibility ratios are similar whether measured in lymphocytes or PAMs of the same individual.
Mclemore et al. 20 have studied AHH activity in PAM, peripheral lymphocytes and fresh lung tissue from lung canc~r patients and control populations. They found a positive correlation between fresh PAM AHH levels and the inducibility of AHH in PAM incubated with BA (i.e., elevated fres·h PAM AHH activity was associated with a higher level of induced enzyme activity). When AHH activity or inducibility in fresh PAM and cultured lymphocytes (PHA and PWM-stimulated) from the same individual were compared for noncancer patients (smoking or nonsmoking), the same positive correlation was observed in the measurements. If AHH activity in fresh PAM, fresh lung tissue and PNA-induced, mitogen-.stimulated lymphocytes was compared for non-cancerous individuals there was a positive correlation between the data obtained in all three tissues. This was not true in lung cancer patients, suggesting that different tissues may be compromised to different extents in their AHH activity in lung cancer patients. The observations conversely suggest-that for non-cancer patients, AHH activity (inducibility) in lymphocytes is indeed an accurate indicator of inhalation exposure to cigarette smoke components.
This same group studied (in a double blind fashion) a group of 64 lung cancer and 51 noncancer patients and compared AHH activities in PAMs with AHH activity in lymphocytes. 18 • 21 • 22 AHH activity in PAM and noninduced and BA-induced lymphocytes of nonsmoking lung cancer patients was significantly higher than in nonsmoking non-cancer patients, but this was not true for smokers. 21 There was a positive correlation between AHH activity data in PAMs and AHH inducibility ratio in lymphocytes for noncancer patients, while there was a dissociation in lung cancer patients. In the case of lung cancer patients who were smokers, there was no consistent correlation between the AHH activities in PAMs and lymphocytes, while in the case of nonsmoking cancer patients, there was an inverse relationship with either high PAM AHH activity and low lymphocyte inducibility or vice versa. These observations indicate a definite effect of cigarette smoke exposure on AHH activity levels in a tissue (lymphocytes) only remotely connected to the portal of entry of the smoke into the body. The reduced AHH inducibility ratio (as compared to a general elevation of AHH induction for this group as a whole) seen in lymphocytes from some nonsmoking cancer patients could be explained by an increased basal activity of the enzyme compared to controls. The authors suggest this elevation of basal activity could be related to past smoking history, as all of the nonsmoking cancer patients had smoked previously, although an average of 20 yrs had passed since cessation of smoking.
Further studies by Mclemore et al. 22 served to elucidate the discrepancies in AHH activities seen in cancer patients. The lung cancer patients could be divided into three categories: (1) high PAM and low lymphocyte AHH levels; (2) low AHH levels in both cell types; and (3) low PAM and high lymphocyte AHH levels. When the highest AHH value (whether in PAM or lymphocyte) was compared for each individual in cancer and noncancer groups, the cancer group was distinctly skewed to higher AHH values. In the case of AHH inducibility ratios in lymphocytes, this skewing is statistically significant. These results help to explain some of the variability of previous reports for it seems clear that a significant percentage 18 of lung cancer patients have non-inducible AHH lymphocyte activities while their AHH activities in other tissues are highly inducible. The distribution of lung cancer patients into the three categories was further analyzed by these workers, who found that the percentage of patients in category 3 with a family history of cancer (39%) was elevated compared to the control group (20% with family history), while the percentage of patients in category 1 with a family history of cancer was decreased. These percentages again suggest that some genetic component may be associated with increased lymphocyte AHH activity and/or inducibility in certain lung cancer patients.
To summarize the results of these complex studies briefly, it appears that AHH activity measurements in a single tissue in lung cancer patients may be misleading, as this could reflect a secondary consequence of the debilitation seen in malignancy. The decrease in AHH inducibility seen in certain lung cancer patients could reflect a diminished response to mitogenic stimulation, for instance. In any case, the results of these investigations with noncancer patients indicate that lymphocyte AHH activity may reliably serve as an indicator of PNA exposure to another tissue. It should finally be noted in regard to these studies that this Texas group uses a modification of the Nebert assay, which again only measures a fraction· of the total metabolites of BP.
Lymphocyte AHH Activity: Relation to Cell Type and Blastogenic Response
The question of the relationship of blastogenic response in mitogenstimulated lymphocytes to AHH activity in these cells has been raised before in this review, and a corollary question of equal importance is the possibility of different cell types having differing levels of AHH activity which are induced to different extents during in vitro culture conditions. This last consideration is of significant importance, since most investigators use mitogen mixtures (PHA and PWM) to stimulate their lymphocyte cultures, and these two mitogens affect different cell types, and in different temporal sequences.
Hart et al. 23 attempted to study more carefully the time-course of induction of human lymphocytes stimulated by PHA and PWM. If MCA is used to superimpose induction upon stimulation, AHH activity increases sharply to a maximum and then declines. This maximal point varied widely (from a minimum of 3 to a maximum of 4 days) from individual to individual as far as time after initiation of culture so that the extent of AHH induction is very dependent upon the time at which the activity measurements are made. DNA synthesis was found to peak at approximately the same time as AHH activity. These authors speculate that the variation in induction of AHH activity is a reflection of variation in extent of lymphoblast transformation.
Prasad et al.
2~
tried to correlate induction (with MCA) of AHH activity in human lymphocytes with PHA responsiveness of these same cells, and found no relationship between AHH inducibility and mitogen response index (as measured by DNA synthesis in PHA-stimulated cells compared to controls). They measured lymphocyte blastogenesis at 91 hrs after PHA addition, however, which is probably not the optimal period of DNA synthesis. Richter et al. 25 agreed with the preceding results when they tried to correlate AHH activity and inducibility with lymphocyte blastogenesis (in response to PHA and PWM) as measured by cell counting. They found there was no obvious relation between growth of lymphocytes Ir1 culture (a presumed measure of mitogen response) and their MeAinduced AHH activity.
In contrast to these results, Kouri et al. 26 found that AHH activity of MCA-induced lymphocytes was highly correlated with the rate of cellular proliferation in response to mitogen (PHA) stimulation (as measured by 3 H-Thy uptake into DNA) for a given individual. This correlation was not observed when proliferation rate and AHH activity were c9mpared in non-induced cultures. These workers also observed that both AHH activity and DNA synthesis rates ( 3 H-Thy uptake) varied significantly with the lot of fetal calf serum used in the culture medium. Kouri et al. 25 suggest that the levels of AHH seen in uninduced (no PNA), mitogen-stimulated lymphocytes are actually a reflection of certain inducers in the culture medium, particularly the feta1 calf ll serum. If this is true, then noninduced AHH values will always be vulnerable to uncontrolled variables inherent in in vitro culture, and inducibility ratios will also suffer from this same defect. They also state that they believe the degree of mitogen activation is a critical reason for AHH activity differences among individuals, so that differences in AHH activity may reflect differences in response to mitogen activation, and not differences in ability to metabolize PNAs. These investigators tried to eliminate some of this variability by using human AB serum in the media rather than FCS, and were apparently successful, as they could now measure significant interindividual differences in AHH activity which were not attributable to differences in mitogen responsiveness.
Gurtoo et al. 27 observed that freshly purified ( 11 resting 11 ) non-PNAinduced lymphocytes had almost no AHH activity, and that AHH activity slowly increased with the length of mitogen stimulation and reached a maximum at 48-72 hrs after addition of mitogen .. They also found that induction of AHH activity by a PNA added 48 hrs post-mitogen was a gradual process, and that maximal induction only occurred after 24 hr exposure to PNAs. DBA was found to be a better inducer than MCA. Using two different AHH assay protocols (their own and Busbee et al. 33 ), Gurtoo et al. 27 found that inducibility ratios (by either method) were in good enough agreement to allow classification of 9 of 10 individuals into the low inducibility group.
The problem of what lymphocyte cell type is responsible for most of the observed AHH activity (if there is a difference in cell types) has been addressed by a few investigators. Gurtoo et al. 28 found that the mitqgenic potency, in terms of mitogen influence on AHH activity, was PHA + PWM > PHA > concanavalin A > PWM ~ no mitogen. They interpreted these results to indicate that 11 T 11 lymphocytes were the primary responder ·cells, since PHA is generally considered to be a 11 lymphocytes and monocytes from peripheral blood, and to measure AHH activities in these three classes of cells. They found evidence that "T" cells had higher levels of AHH activity (as determined by a radiometric assay) than did "B" cells, although this enhancement was variable in extent. The validity of this result, however, depends upon the relative effectiveness of mitogenic stimulation of the two subclasses of lymphocytes, and the authors give no evidence that their mixture of PHA and PWM was equally stimulatory to both types of cells. Jett et al . 29 also observed that monocyte-depleted lymphocyte cultures had decreased AHH activity compared to peripheral blood mononuclear cultures (lymphocytes + monocytes) and suggest that monocytes may contribute to total observed AHH activity. AHH activity can also be detected in certain human lymphoblastoid ·lines derived from human blood samples. Freedman et al. 30 • 31 found that some human lymphoblastoid lines (particularly RPM! 1788) have AHH activity which is not dependent on mitogen stimulation, and that such activity can be induced to different extents by the use of various PNAs.
AHH Activity Assays: Reliability and Relationship of Assay to Metabolism
The preceding studies may serve to illustrate the complexity of the total picture of AHH activity in human lymphocytes and to illustrate the most vexing aspects of all these studies, namely, the lack of reproducibility in the AHH assays, and the apparent conflicting results obtained by different workers. Some of this apparent conflict is clearly due to differences in protocol, i.e., different time sequences of mitogen stimulation, different PNA induction schedules, the use of different culture media, etc., but the most disturbing results concern the apparent intra-individual variability seen in the results of individual groups each using a particular assay method. Several groups have attempted to identify the sources of irreproducibility in various AHH assays.
Gurtoo et al. 28 refined much of the protocol for the lymphocyte AHH assay, such as type of culture flask used, the cell plating density, the concentration of fetal calf serum in the culture medium, the type of mitogen used, etc. Among the results reported were: (1) different lots of fetal calf serum significantly affected AHH activity; (2) AHH activities based on DNA content were more reliable than based on cell number.
Gurtoo et al.
32 also used a number of potential inducers and inhibitors of AHH in attempting to characterize the nature of the AHH activity in lymphocytes, hoping to find basic differences between the basal and induced enzyme which might be more reproducibly measured than the enzyme activity itself. No substantive differences in response to AHH inhibitors, in enzyme half-life, or in enzyme kinetic parameters were observed between the basal and induced enzyme, suggesting that both basal and induced AHH activity resulted from the same constituent enzyme protein.
They observed that phenobarbital did not induce lymphocyte AHH activity. Gurtoo et al. 32 also noted that 2,3,7,8-tetrachlorodibenzo-p-dioxin, BA and DBA were all more potent inducers of lymphocyte AHH activity than was MCA. Gurtoo et al. 33 continued their investigation of basal vs induced AHH activities in lymphocytes by studying BP metabolite profiles using high performance liquid chromatography (HPLC). They compared metabolite profiles from uninduced and SA-induced lymphocytes of donors with low and high inducibility ratios, and found no qualitative differences between uninduced and induced profiles in either case. The range of metabolites produced included the BP 9,10-diol, the 7,8-diol, phenols, including 3 and 9-hydroxy, and quinones, which were not further separated. There were quantitative differences in metabolite profiles from low and high inducibility ratio donors: the amount of phenol formation from induced cells correlated very well with inducibility ratios (i.e., phenol formation from donor lymphocytes with high inducibility was greater than from donors w.ith low inducibility); the amount of phenol formation in basal cells did not correlate well with donor inducibility ratios; formation of 7,8-diol in induced cells did not parallel phenol formation (i.e., no correlation with donor inducibility). One might speculate that the quantitative differences in phenol formation (which parallel donor inducibility ratios), along with lack of such parallelism in the formation of other metabolites, may be a reflection of altered· enzymatic activity upon PNA induction. In any case, the parallelism of phenol formation with AHH inducibility makes clear the observations of so many workers in the preceding decade. Almost all of these investigators used the Nebert assay, which measures fluorescence of phenols (mainly 3-hydroxy). If induced lymphocytes produce more phenols, and these (and only these!) are measured in the assay, then it is not surprising that an increase in AHH activity is observed upon PNA exposure.
The disturbing possibility exists that this measurement of phenol production may not really be an accurate reflection of AHM activity, either basal or induced.
This question of SP metabolite formation by basal and induced forms of lymphocyte AHH has been carefully analyzed by Okano et al. 34 They found that SA-induced lymphocytes produced a variety of SP metabolites including the (4,5), (7, 8) and (9,1~)-diols, the 3,7, and 9 phenols and the (1 ,6) and (6,12)-quinones. Of the dials, the 7,8-diol is formed in most abundance, while in the case of the phenols, 3 hydroxy was always formed in greater quantity than the 9-hydroxy. When basal and SAinduced lymphocytes are compared in terms of SP metabolite formation, the induced cells show the greatest increases in 7 and 9-hydroxy formation and relatively lesser increases in 3-hydroxy and 7,8-diol formation.
SUMMARY
The studies discussed in this report are summarized chronologically in Table 1 . Suffice it to say that the AHM enzyme system in lymphocytes clearly shows promise as a potentially useful biomarker for PNA exposure, but that the problems associated with blastogenesis, assay reliability, etc. must first be addressed before this potential is realized. 
